The Prothrombin (Factor II) 20210G?A Mutation Analysis test contains 1 test with 2 biomarkers.
Factor II Mutation (G20210A) is one of the most common causes of venous thrombosis. 2.3% of the general population is heterozygous in contrast with 6.2% of patients with venous thrombosis and 18% with familial venous thrombosis. Other risk factors compound the risk for venous thrombosis.
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Prothrombin Factor II 20210GA Mutation Analysis
Biomarkers 2
Interpretation
Prothrombin (Factor Ii)
*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.